bioRxivPhysiologyPreprint
Lipid mobilization establishes metabolic tolerance and prevents autonomic collapse in infection
Ankita Sarkar, Shangkui Xie, Syed Kazim Rizvi, Tadiwanashe Gwatiringa, Sophie Heston, Samuel PiakeriD, Narges AlipanahiD, Jianyi YiniD, Laurent Gautron, Soumya Kamath, Neena Alex, Ashutosh ShuklaiD, Lin JiaiD, Rani Shiao, Lauren E Kemp, David G. Thomas, Alexander M. TataraiD, Catherine CheniD, Mujeeb Basit, Xiao‐Fei KongiD, Vanessa NomelliniiD, Anoj IlangesiD, Samuel Heaselgrave, Joel Keith ElmquistiD, Heather W. Stout-DelgadoiD, , Suraj J. PateliD
Abstract
Survival during infection depends on both pathogen clearance and the ability to tolerate infection-induced physiological changes. Metabolic adaptations are a central component of this tolerance, but the mechanisms underlying these responses remain incompletely defined. Here, we identify white adipose tissue (WAT) lipolysis as a central regulator of metabolic tolerance to infection. In patients with sepsis, higher circulating non-esterified fatty acid (NEFA) levels were associated with reduced mortality. In mouse models of polymicrobial sepsis, infection induced robust adipose lipolysis and increased circulating NEFAs. Genetic ablation of adipose triglyceride lipase (ATGL) in adipose tissue impaired lipolysis, leading to hypothermia, bradycardia, and increased mortality without altering immune cell populations or pathogen burden, consistent with a defect in tolerance rather than resistance. Mechanistically, lipolysis-derived NEFAs, but not glycerol, were required for protection, as restoring circulating NEFAs rescued autonomic stability and survival in adipose tissue ATGL-deficient mice. Infection-induced lipolysis was redundantly regulated and did not depend on any single upstream signaling pathway. Both pharmacologic activation of lipolysis using a {beta}3-adrenergic agonist and exogenous fatty acid supplementation increased circulating NEFAs, improved survival, and promoted tolerance in mice. Consistent with these findings, analysis of real-world electronic health record data demonstrated that septic patients receiving FDA-approved {beta}3-adrenergic agonists had reduced mortality or hospice discharge in a propensity-matched cohort. Together, these results identify WAT lipolysis and circulating fatty acids as key mediators of tolerance to infection and support a therapeutic strategy based on repurposing clinically available {beta}3-adrenergic agonists to improve outcomes in sepsis. One Sentence SummaryWhite adipose tissue lipolysis promotes metabolic tolerance to infection through circulating fatty acids and is associated with improved survival in sepsis
- organism: human
- organism: mouse
- assay: metabolomics
- research focus: host-pathogen & immune response
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A bioenergetic basis for multiorgan dysfunction in sepsis
Elisa Jentho, Temitope Wilson Ademolue, … Miguel Parreira Soares·bioRxiv·Jun 12, 2025
- Transient protein phosphorylation promotes disease tolerance to sepsis
Wolfgang Vivas, Johannes Roth, … Sebastian Weis·bioRxiv·Jun 10, 2026
- SEPSIS-INDUCED LIPID DROPLET ACCUMULATION ENHANCES ANTIBACTERIAL INNATE IMMUNITY
Filipe Santos Pereira-Dutra, Julia Cunha Santos, … Patrícia Torres Bozza·bioRxiv·Jan 29, 2025
- Ketone and glycolytic metabolism are key modulators of inflammation during neonatal sepsis
Björn Klabunde, Ole Bæk, … Duc Ninh Nguyen·bioRxiv·Aug 15, 2025
- Regulation of host metabolism and defense strategies to survive neonatal infection
Z. Wu, N. T. N. Tien, … D. N. Nguyen·bioRxiv·Feb 23, 2024
- Hepatic Nrf1 (Nfe2l1) promotes VLDL dependent liver defense against sepsis
Michael J. Trites, Lei Li, … Scott B. Widenmaier·Cellular and Molecular Gastroenterology and HepatologyPeer-reviewed·Jan 1, 2025